{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:39:29Z","timestamp":1793392769255,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Construction and validation of prediction model for occurrence and severity of metabolism-related fatty liver disease."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04017-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:12:45Z","timestamp":1751353965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["The diagnostic value of MRI-PDFF in hepatic steatosis of patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Yue-Xia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ping","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Lei","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"5","key":"4017_CR1","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, She ZG, Zhu L, Cai J, Li H. Epidemiological features of MASLD from 1999 to 2018 in China. Hepatology. 2020;71(5):1851\u201364.","journal-title":"Hepatology"},{"issue":"1","key":"4017_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123\u201333.","journal-title":"Hepatology"},{"issue":"7","key":"4017_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of MASLD development and therapeutic strategies. Nat Med. 2018;24(7):908\u201322.","journal-title":"Nat Med"},{"issue":"6","key":"4017_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1053\/j.sult.2016.08.003","volume":"37","author":"IS Idilman","year":"2016","unstructured":"Idilman IS, Ozdeniz I, Karcaaltincaba M. Hepatic steatosis: etiology, patterns, and quantification. Semin Ultrasound CT MR. 2016;37(6):501\u201310.","journal-title":"Semin Ultrasound CT MR"},{"issue":"18","key":"4017_CR5","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75(18):3313\u201327.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"4017_CR6","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/hep.28390","volume":"63","author":"A Unalp-Arida","year":"2016","unstructured":"Unalp-Arida A, Ruhl CE. Noninvasive fatty liver markers predict liver disease mortality in the U.S. Population. Hepatology. 2016;63(4):1170\u201383.","journal-title":"Hepatology"},{"issue":"10","key":"4017_CR7","first-page":"823","volume":"26","author":"JF Cadranel","year":"2002","unstructured":"Cadranel JF. Recommandations pour La pratique clinique pour La r\u00e9alisation de La ponction biopsie h\u00e9patique [Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future]. Gastroenterol Clin Biol. 2002;26(10):823\u20134. French.","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"4017_CR8","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/hep.21346","volume":"44","author":"RB Merriman","year":"2006","unstructured":"Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, Bass NM. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology. 2006;44(4):874\u201380.","journal-title":"Hepatology"},{"issue":"1","key":"4017_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhep.2008.10.014","volume":"50","author":"P Bedossa","year":"2009","unstructured":"Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol. 2009;50(1):1\u20133.","journal-title":"J Hepatol"},{"issue":"1","key":"4017_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.cld.2017.08.004","volume":"22","author":"E Tsai","year":"2018","unstructured":"Tsai E, Lee TP. Diagnosis and evaluation of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis, including noninvasive biomarkers and transient elastography. Clin Liver Dis. 2018;22(1):73\u201392.","journal-title":"Clin Liver Dis"},{"key":"4017_CR11","doi-asserted-by":"publisher","first-page":"9729107","DOI":"10.1155\/2017\/9729107","volume":"2017","author":"L He","year":"2017","unstructured":"He L, Deng L, Zhang Q, Guo J, Zhou J, Song W, Yuan F. Diagnostic value of CK-18, FGF-21, and related biomarker panel in nonalcoholic fatty liver disease: A systematic review and Meta-Analysis. Biomed Res Int. 2017;2017:9729107.","journal-title":"Biomed Res Int"},{"issue":"5","key":"4017_CR12","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","volume":"156","author":"L Castera","year":"2019","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264\u2013e12814.","journal-title":"Gastroenterology"},{"issue":"5","key":"4017_CR13","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/jmri.21957","volume":"30","author":"CD Hines","year":"2009","unstructured":"Hines CD, Yu H, Shimakawa A, McKenzie CA, Brittain JH, Reeder SB. T1 independent, T2* corrected MRI with accurate spectral modeling for quantification of fat: validation in a fat-water-SPIO Phantom. J Magn Reson Imaging. 2009;30(5):1215\u201322.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"4017_CR14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00261-019-02350-3","volume":"45","author":"GM Cunha","year":"2020","unstructured":"Cunha GM, Thai TT, Hamilton G, Covarrubias Y, Schlein A, Middleton MS, Wiens CN, McMillan A, Agni R, Funk LM, Campos GM, Horgan S, Jacobson G, Wolfson T, Gamst A, Schwimmer JB, Reeder SB, Sirlin CB. Accuracy of common proton density fat fraction thresholds for magnitude- and complex-based chemical shift-encoded MRI for assessing hepatic steatosis in patients with obesity. Abdom Radiol (NY). 2020;45(3):661\u201371.","journal-title":"Abdom Radiol (NY)"},{"issue":"3","key":"4017_CR15","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","volume":"152","author":"CC Park","year":"2017","unstructured":"Park CC, Nguyen P, Hernandez C, Bettencourt R, Ramirez K, Fortney L, Hooker J, Sy E, Savides MT, Alquiraish MH, Valasek MA, Rizo E, Richards L, Brenner D, Sirlin CB, Loomba R. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with Biopsy-Proven nonalcoholic fatty liver disease. Gastroenterology. 2017;152(3):598\u2013e6072.","journal-title":"Gastroenterology"},{"key":"4017_CR16","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"8","key":"4017_CR17","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336.","journal-title":"Ann Intern Med"},{"issue":"2","key":"4017_CR18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1148\/radiol.12120896","volume":"267","author":"A Tang","year":"2013","unstructured":"Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, Gamst AC, Middleton M, Brunt EM, Loomba R, Lavine JE, Schwimmer JB, Sirlin CB. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013;267(2):422\u201331.","journal-title":"Radiology"},{"issue":"2","key":"4017_CR19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1148\/radiol.14140754","volume":"274","author":"A Tang","year":"2015","unstructured":"Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, Clark L, Hooker J, Chavez T, Ang BD, Middleton MS, Peterson M, Loomba R, Sirlin CB. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology. 2015;274(2):416\u201325.","journal-title":"Radiology"},{"issue":"3","key":"4017_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","volume":"150","author":"K Imajo","year":"2016","unstructured":"Imajo K, Kessoku T, Honda Y, Tomeno W, Ogawa Y, Mawatari H, Fujita K, Yoneda M, Taguri M, Hyogo H, Sumida Y, Ono M, Eguchi Y, Inoue T, Yamanaka T, Wada K, Saito S, Nakajima A. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology. 2016;150(3):626\u2013e6377.","journal-title":"Gastroenterology"},{"issue":"39","key":"4017_CR21","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.3748\/wjg.v22.i39.8812","volume":"22","author":"M Di Martino","year":"2016","unstructured":"Di Martino M, Pacifico L, Bezzi M, Di Miscio R, Sacconi B, Chiesa C, Catalano C. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents. World J Gastroenterol. 2016;22(39):8812\u20139.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"4017_CR22","doi-asserted-by":"publisher","first-page":"W168","DOI":"10.2214\/AJR.16.16726","volume":"208","author":"JS Paige","year":"2017","unstructured":"Paige JS, Bernstein GS, Heba E, Costa EAC, Fereirra M, Wolfson T, Gamst AC, Valasek MA, Lin GY, Han A, Erdman JW Jr, O\u2019Brien WD Jr, Andre MP, Loomba R, Sirlin CB. A pilot comparative study of quantitative ultrasound, conventional ultrasound, and MRI for predicting Histology-Determined steatosis grade in adult nonalcoholic fatty liver disease. AJR Am J Roentgenol. 2017;208(5):W168\u201377.","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"4017_CR23","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1053\/j.gastro.2017.06.005","volume":"153","author":"MS Middleton","year":"2017","unstructured":"Middleton MS, Heba ER, Hooker CA, Bashir MR, Fowler KJ, Sandrasegaran K, Brunt EM, Kleiner DE, Doo E, Van Natta ML, Lavine JE, Neuschwander-Tetri BA, Sanyal A, Loomba R, Sirlin CB, NASH Clinical Research Network. Agreement between magnetic resonance imaging proton density fat fraction measurements and Pathologist-Assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology. 2017;153(3):753\u201361.","journal-title":"Gastroenterology"},{"issue":"3","key":"4017_CR24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/hep.29596","volume":"67","author":"MS Middleton","year":"2018","unstructured":"Middleton MS, Van Natta ML, Heba ER, Alazraki A, Trout AT, Masand P, Brunt EM, Kleiner DE, Doo E, Tonascia J, Lavine JE, Shen W, Hamilton G, Schwimmer JB, Sirlin CB. NASH clinical research network. Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology. 2018;67(3):858\u201372.","journal-title":"Hepatology"},{"issue":"6","key":"4017_CR25","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.21037\/qims.2019.05.20","volume":"9","author":"F Hu","year":"2019","unstructured":"Hu F, Yang R, Huang Z, Wang M, Yuan F, Xia C, Wei Y, Song B. 3D Multi-Echo Dixon technique for simultaneous assessment of liver steatosis and iron overload in patients with chronic liver diseases: a feasibility study. Quant Imaging Med Surg. 2019;9(6):1014\u201324.","journal-title":"Quant Imaging Med Surg"},{"issue":"4","key":"4017_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","volume":"75","author":"EA Selvaraj","year":"2021","unstructured":"Selvaraj EA, M\u00f3zes FE, Jayaswal ANA, Zafarmand MH, Vali Y, Lee JA, Levick CK, Young LAJ, Palaniyappan N, Liu CH, Aithal GP, Romero-G\u00f3mez M, Brosnan MJ, Tuthill TA, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M. LITMUS investigators. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with MASLD: A systematic review and meta-analysis. J Hepatol. 2021;75(4):770\u201385.","journal-title":"J Hepatol"},{"issue":"3","key":"4017_CR27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/hep.25731","volume":"56","author":"TA Le","year":"2012","unstructured":"Le TA, Chen J, Changchien C, Peterson MR, Kono Y, Patton H, Cohen BL, Brenner D, Sirlin C, Loomba R, San Diego Integrated MASLD Research Consortium (SINC). Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology. 2012;56(3):922\u201332.","journal-title":"Hepatology"},{"issue":"12","key":"4017_CR28","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","volume":"29","author":"L Sandrin","year":"2003","unstructured":"Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, Beaugrand M, Palau R. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705\u201313.","journal-title":"Ultrasound Med Biol"},{"key":"4017_CR29","doi-asserted-by":"publisher","first-page":"1087260","DOI":"10.3389\/fendo.2022.1087260","volume":"13","author":"L Rong","year":"2023","unstructured":"Rong L, Zou J, Ran W, Qi X, Chen Y, Cui H, Guo J. Advancements in the treatment of non-alcoholic fatty liver disease (MASLD). Front Endocrinol (Lausanne). 2023;13:1087260.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"4017_CR30","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/hep.27647","volume":"61","author":"R Loomba","year":"2015","unstructured":"Loomba R, Sirlin CB, Ang B, Bettencourt R, Jain R, Salotti J, Soaft L, Hooker J, Kono Y, Bhatt A, Hernandez L, Nguyen P, Noureddin M, Haufe W, Hooker C, Yin M, Ehman R, Lin GY, Valasek MA, Brenner DA, Richards L. San Diego integrated MASLD research consortium (SINC). Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology. 2015;61(4):1239\u201350.","journal-title":"Hepatology"},{"issue":"2","key":"4017_CR31","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jhep.2016.04.021","volume":"65","author":"J Cui","year":"2016","unstructured":"Cui J, Philo L, Nguyen P, Hofflich H, Hernandez C, Bettencourt R, Richards L, Salotti J, Bhatt A, Hooker J, Haufe W, Hooker C, Brenner DA, Sirlin CB, Loomba R. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial. J Hepatol. 2016;65(2):369\u201376.","journal-title":"J Hepatol"},{"issue":"6","key":"4017_CR32","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/hep.26455","volume":"58","author":"M Noureddin","year":"2013","unstructured":"Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, Bettencourt R, Changchien C, Brenner DA, Sirlin C, Loomba R. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology. 2013;58(6):1930\u201340.","journal-title":"Hepatology"},{"issue":"5","key":"4017_CR33","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1177\/1756283X16656735","volume":"9","author":"J Patel","year":"2016","unstructured":"Patel J, Bettencourt R, Cui J, Salotti J, Hooker J, Bhatt A, Hernandez C, Nguyen P, Aryafar H, Valasek M, Haufe W, Hooker C, Richards L, Sirlin CB, Loomba R. Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis. Th Adv Gastroenterol. 2016;9(5):692\u2013701.","journal-title":"Th Adv Gastroenterol"},{"issue":"2","key":"4017_CR34","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/hep.29797","volume":"68","author":"C Caussy","year":"2018","unstructured":"Caussy C, Reeder SB, Sirlin CB, Loomba R, Noninvasive. Quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology. 2018;68(2):763\u201372.","journal-title":"Hepatology"},{"issue":"4","key":"4017_CR35","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1007\/s00330-024-11001-1","volume":"35","author":"N AZIZI","year":"2025","unstructured":"Azizi N, Naghibi H, Shakiba M, et al. Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis [J]. Eur Radiol. 2025;35(4):1794\u2013807.","journal-title":"Eur Radiol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04017-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04017-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04017-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:12:46Z","timestamp":1751353966000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04017-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4017"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04017-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"451"}}